European Price Cuts Likely To Be Above Normal This Year, Says EFPIA President Witty
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK's Witty urges European companies to work with government payers.
You may also be interested in...
European Pricing Discontent: A Summer Of Freezes, Cutbacks And Austerity
Over the past few months, cuts to pharmaceutical prices have been announced in Ireland, Germany and Greece. France, Spain and Italy are preparing to make similar moves
Novo Nordisk Faced Tough Decision in Greece: Cut Prices And Make A Loss Or Oppose Government Plans
Danish drug maker turns up pressure on Greek government to reverse its price cut demands.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.